The depo lawsuit is heading into 2026 with real momentum, and thousands of women are watching closely. Cases linking Depo-Provera injections to meningioma brain tumors are now consolidated in federal court. Bellwether trials are on the calendar, and the first settlement signals could arrive this year.
This article breaks down everything you need to know about the 2026 landscape. You will find projected payout ranges, eligibility rules, filing deadlines, and the key court dates that matter.
Here is one number worth remembering: researchers found that long-term Depo-Provera users face up to a 5.5 times higher risk of developing meningioma compared to non-users. That statistic is driving this entire wave of litigation.
If you received Depo-Provera shots and later developed a brain tumor, this guide was written for you.
Depo Lawsuit 2026: What You Need to Know Right Now
The depo lawsuit in 2026 is a mass tort action against Pfizer alleging that Depo-Provera injections caused meningioma brain tumors in thousands of women. The litigation is centralized under MDL No. 3127 in the U.S. District Court for the Northern District of Alabama.
As of early 2026, more than 8,000 individual cases have been filed. That number continues growing as more women connect their diagnoses to years of Depo-Provera use.
Judge Liles C. Burke is overseeing the consolidated litigation. The Plaintiffs’ Steering Committee has been working through discovery and preparing cases for bellwether trials.
| Detail | Info |
|---|---|
| Case Name | In Re: Depo-Provera Contraceptive Injection MDL |
| MDL Number | 3127 |
| Court | N.D. Alabama |
| Judge | Liles C. Burke |
| Defendant | Pfizer Inc. |
| Cases Filed | 8,000+ |
| Key Allegation | Meningioma brain tumors |
Pfizer has denied liability and maintains that Depo-Provera is safe when used as directed. But the volume of scientific evidence and growing plaintiff numbers tell a different story.
The outcome of this litigation could set precedent for pharmaceutical product liability cases for years to come.
Depo Provera Lawsuit Update 2026
The most significant update for 2026 is the approach of bellwether trials. These are test cases selected by both sides to gauge how juries respond to the evidence.
Discovery has moved forward through late 2025 and into 2026. Both Pfizer and the plaintiffs have exchanged thousands of internal documents, expert witness reports, and medical records.
Pfizer’s internal communications are expected to be a focal point. Plaintiffs allege the company knew about the meningioma risk for years but failed to update its warning labels adequately.
The FDA has not recalled Depo-Provera. However, updated label language regarding meningioma risk was added in 2024, which plaintiffs point to as evidence that the risk was always real.
New plaintiffs continue filing cases in early 2026. Many women report they only learned about the brain tumor connection through news coverage of the MDL.
- Over 8,000 cases consolidated as of early 2026
- Bellwether trial preparation is actively underway
- Pfizer internal documents under review by plaintiffs’ attorneys
- FDA label update in 2024 bolsters plaintiffs’ claims
- New cases still being accepted by law firms nationwide
Depo Provera Lawsuit Settlement Amounts 2026
No official settlement has been reached in the Depo-Provera litigation as of early 2026. Settlement talks are not expected to gain serious traction until after the first bellwether trial results come in.
That said, legal analysts and mass tort attorneys have projected potential settlement ranges based on similar pharmaceutical cases. Brain tumor cases involving surgical intervention typically settle for higher amounts than cases involving only monitoring.
| Injury Tier | Projected Settlement Range |
|---|---|
| Tier 1: Meningioma requiring surgery | $200,000 to $500,000+ |
| Tier 2: Meningioma requiring radiation | $150,000 to $350,000 |
| Tier 3: Diagnosed meningioma, monitored | $50,000 to $150,000 |
| Tier 4: Other qualifying brain tumors | $25,000 to $100,000 |
These numbers are projections, not guarantees. Actual payouts depend on bellwether outcomes, the strength of individual evidence, and whether Pfizer chooses to negotiate or fight every case.
Think of bellwether trials like a test run. If juries award large verdicts, Pfizer has strong incentive to settle the remaining cases. If verdicts favor the defense, settlement values drop.
The total settlement fund could reach into the billions given the plaintiff count. Similar mass tort cases like the Roundup litigation resulted in settlements exceeding $10 billion.
Key Takeaway: The depo lawsuit enters 2026 with thousands of cases filed, bellwether trials approaching, and projected individual payouts ranging from $25,000 to over $500,000 depending on injury severity.
Depo Provera Settlement Payout Per Person
The per-person payout in a Depo-Provera settlement will vary significantly based on individual circumstances. There is no flat-rate payment. Each claim is evaluated on its own merits.
Several factors determine how much a single claimant could receive. Duration of Depo-Provera use matters. So does the severity of the brain tumor diagnosis and the treatment required.
| Factor | Higher Payout | Lower Payout |
|---|---|---|
| Duration of Use | 5+ years | Less than 1 year |
| Tumor Treatment | Surgery performed | Monitoring only |
| Tumor Size | Large or multiple tumors | Small, single tumor |
| Impact on Life | Disability, job loss | Minimal disruption |
| Medical Records | Complete documentation | Gaps in records |
| Age at Diagnosis | Younger patients | Older patients |
Women who underwent brain surgery, experienced lasting neurological damage, or lost their ability to work will likely receive the highest payouts.
A woman who used Depo-Provera for eight years and needed two surgeries to remove a meningioma is in a very different position than someone diagnosed with a small, slow-growing tumor that doctors are simply watching.
Both cases may qualify. But the compensation will reflect the difference in suffering and medical cost.
Who Qualifies for the Depo Provera Lawsuit
You may qualify for the Depo-Provera lawsuit if you received Depo-Provera injections and were later diagnosed with a meningioma or another intracranial tumor. That is the basic threshold.
Most law firms handling these cases look for the following criteria:
- You received at least one Depo-Provera injection
- You were diagnosed with meningioma after starting Depo-Provera
- Your diagnosis occurred during or after the period of injections
- You have medical records confirming both the injections and the diagnosis
The stronger cases involve women who used Depo-Provera for extended periods, typically one year or longer. Research shows the risk increases with cumulative exposure.
Family members may also have standing to file claims. If a woman died from complications related to a meningioma linked to Depo-Provera, a wrongful death claim may be possible.
Women who used the generic version of the drug (medroxyprogesterone acetate injections) may also qualify. The active ingredient is the same regardless of brand name.
Depo Provera Lawsuit Eligibility Requirements
Eligibility requires documented proof of both Depo-Provera use and a qualifying diagnosis. Claims without medical records will struggle to move forward.
Here is what attorneys typically need to evaluate your case:
- Pharmacy records showing Depo-Provera prescriptions filled
- Medical records documenting meningioma or brain tumor diagnosis
- Imaging results such as MRI or CT scans showing the tumor
- Treatment records including surgery reports, radiation records, or monitoring logs
- Timeline documentation connecting the injection period to the diagnosis
Your health insurance records can also serve as backup evidence. They often show injection dates and diagnostic codes for brain tumors.
| Eligibility Criteria | Required or Helpful |
|---|---|
| Proof of Depo-Provera use | Required |
| Meningioma diagnosis | Required |
| MRI or CT scan results | Required |
| Surgery or treatment records | Helpful, increases value |
| Pharmacy fill records | Helpful |
| Doctor’s notes linking use to diagnosis | Helpful |
One common question: do you need to have been diagnosed recently? Not necessarily. Women diagnosed years ago may still qualify if they fall within the statute of limitations for their state.
Key Takeaway: You likely qualify if you received Depo-Provera injections and were diagnosed with a meningioma, but strong medical records documenting both are essential to building a viable claim.
Depo Provera Meningioma Lawsuit Explained
The Depo-Provera meningioma lawsuit centers on the claim that the synthetic progestin in Depo-Provera (medroxyprogesterone acetate) stimulates the growth of meningioma tumors in the brain. Meningiomas are tumors that form on the membranes surrounding the brain and spinal cord.
While most meningiomas are classified as benign, that word is misleading. A “benign” brain tumor can still cause seizures, vision loss, hearing damage, cognitive decline, and require invasive surgery to remove.
The scientific basis for these lawsuits comes from multiple studies. A landmark 2024 French cohort study published by researchers affiliated with ANSM (France’s national drug safety agency) found that prolonged use of injectable medroxyprogesterone acetate was associated with a 5.5 times higher risk of intracranial meningioma.
Earlier research published in the BMJ had already flagged this connection. The WHO classifies medroxyprogesterone acetate as a hormonal agent with known tumor-related concerns.
Plaintiffs argue that Pfizer (and its predecessor Pharmacia and Upjohn Company) knew or should have known about these risks. The core accusation is failure to warn. Pfizer’s product labeling did not adequately disclose the meningioma risk for decades.
The 2024 FDA label update, which added meningioma language, strengthens this argument. If the risk was worth adding to the label in 2024, plaintiffs ask, why was it missing for the previous 30 years?
Depo Provera Side Effects Linked to Lawsuits
The primary side effect driving the Depo-Provera lawsuits is meningioma, a type of brain tumor. But the full list of reported side effects is broader than many patients realize.
Women in the litigation have reported the following conditions after receiving Depo-Provera injections:
- Meningioma (intracranial brain tumor)
- Multiple meningiomas (more than one tumor)
- Seizures related to tumor pressure
- Vision loss or blurred vision
- Chronic headaches and migraines
- Hearing loss
- Cognitive impairment and memory problems
- Paralysis or weakness on one side of the body
Not every side effect on this list will support a standalone lawsuit. The litigation is focused specifically on brain tumors, with meningioma being the central diagnosis.
However, the secondary symptoms caused by the tumor (seizures, vision loss, cognitive decline) are factored into the overall damages calculation. A woman who went blind in one eye because a meningioma compressed her optic nerve has suffered far more than someone whose tumor was caught early.
It is worth understanding that meningiomas can be slow-growing. Some women received Depo-Provera in the early 2000s and were not diagnosed with a tumor until 2020 or later. The latency period can span many years.
Depo Provera Lawsuit Timeline for 2026
The Depo-Provera lawsuit timeline for 2026 includes several critical milestones that will shape the entire litigation. Bellwether case selection, expert depositions, and possible trial dates are all on the calendar.
| Timeline Event | Expected Timing |
|---|---|
| Ongoing discovery and document exchange | Q1 2026 |
| Expert witness depositions | Q1 to Q2 2026 |
| Bellwether case selection finalized | Mid 2026 |
| Daubert hearings (expert challenges) | Mid 2026 |
| First bellwether trial | Late 2026 to early 2027 |
| Potential settlement discussions | After first verdict |
Discovery is where the real action happens before trial. Both sides have exchanged internal emails, research reports, marketing materials, and safety data. Pfizer’s internal knowledge about the meningioma risk is a central issue.
Daubert hearings are scheduled where Pfizer will challenge the plaintiffs’ expert witnesses. If the court allows the scientific testimony to proceed, the case becomes much harder for Pfizer to defend.
Think of 2026 as the year the pieces get placed on the board before the real game begins. Settlement talks rarely start in earnest until a bellwether verdict gives both sides a reality check.
Key Takeaway: The year 2026 is packed with pretrial activity, and the first bellwether trial could come as early as late 2026, setting the stage for potential settlement negotiations.
Depo Provera MDL 2026 Status
MDL No. 3127 is the multidistrict litigation consolidating all federal Depo-Provera meningioma cases. It is housed in the Northern District of Alabama under Judge Liles C. Burke.
An MDL is not a class action. Each plaintiff keeps their own individual case. The MDL structure simply groups cases together for pretrial efficiency. Shared discovery, coordinated motions, and bellwether trials all happen in one courtroom.
As of 2026, the MDL has grown to over 8,000 cases. New transfer orders from the Judicial Panel on Multidistrict Litigation (JPML) continue adding cases monthly.
The Plaintiffs’ Steering Committee leads the litigation on behalf of all claimants. This committee selects bellwether cases, coordinates expert witnesses, and negotiates with Pfizer’s legal team.
- MDL Number: 3127
- Court: U.S. District Court, Northern District of Alabama
- Judge: Liles C. Burke
- Total Cases: 8,000+
- Status: Active pretrial phase
- Defendant: Pfizer Inc.
State court cases also exist. Some plaintiffs have filed in state courts where they believe they may receive more favorable treatment. These cases operate independently from the MDL but often track its progress.
If the MDL produces a global settlement, it would likely cover both federal and state cases. But that scenario is still months or years away.
Depo Provera Bellwether Trial 2026
A bellwether trial is a test case tried before a jury to help both sides evaluate the strength of their arguments. The first Depo-Provera bellwether trial could take place in late 2026 or early 2027.
Bellwether cases are carefully selected. The plaintiffs want cases with strong medical evidence, clear timelines, and sympathetic facts. The defense wants cases where causation is harder to prove.
Typically, each side proposes a pool of cases. The judge then selects a handful to go to trial first. These verdicts do not bind other plaintiffs, but they carry enormous practical weight.
| Bellwether Detail | Info |
|---|---|
| Purpose | Test case to gauge jury response |
| Selection | Both sides propose candidates |
| Number of trials | Usually 3 to 5 initial cases |
| Binding on others? | No, but highly influential |
| Expected timing | Late 2026 to early 2027 |
| Impact on settlement | A large verdict accelerates talks |
If the first bellwether jury awards a plaintiff $5 million or more, Pfizer’s calculation changes overnight. The company faces the prospect of repeating that outcome thousands of times.
On the flip side, a defense verdict gives Pfizer leverage to offer lower settlements or push for individual trials. That is why both sides take bellwether selection extremely seriously.
Picture it like a poker hand. The bellwether trial reveals what cards each side is holding. Everything after that becomes a negotiation.
Is the Depo Provera Lawsuit a Class Action
The Depo-Provera lawsuit is not a class action. It is a mass tort consolidated as a multidistrict litigation (MDL). The difference matters and directly affects how much money individual claimants can receive.
In a class action, one or a few plaintiffs represent everyone. Any settlement gets divided equally or by formula among all class members. Individual circumstances often get averaged out.
In a mass tort MDL, every plaintiff has their own separate case. Your payout is based on your specific injuries, your medical records, and your individual damages. This means a woman who had brain surgery could receive far more than someone with a monitored tumor.
| Feature | Class Action | Mass Tort MDL |
|---|---|---|
| Individual cases | No | Yes |
| Personalized payout | Rarely | Yes |
| Your own attorney | Optional | Yes |
| Settle individually | No | Possible |
| Share evidence | N/A | Yes, coordinated |
The MDL structure benefits plaintiffs in this situation because brain tumor injuries vary so widely. A one-size-fits-all class action payout would fail to account for the difference between a woman who lost her vision and a woman whose tumor shrank on its own.
Some people use the term “class action” casually to describe any large lawsuit. But legally, the Depo-Provera litigation is structured to preserve each person’s individual claim.
Key Takeaway: The Depo-Provera case is a mass tort MDL, not a class action, meaning each plaintiff’s payout will reflect their individual injuries and medical history rather than a flat per-person amount.
Depo Provera Lawsuit Deadline 2026
Filing deadlines for the Depo-Provera lawsuit depend on your state’s statute of limitations. There is no single federal deadline that applies to every claimant.
Most states allow two to three years from the date you discovered (or should have discovered) the connection between Depo-Provera and your brain tumor. This is called the “discovery rule.”
| State Example | Statute of Limitations | Discovery Rule |
|---|---|---|
| California | 2 years | Yes |
| Texas | 2 years | Yes |
| New York | 3 years | Yes |
| Florida | 2 years (recently changed) | Yes |
| Illinois | 2 years | Yes |
| Pennsylvania | 2 years | Yes |
Because news coverage of the Depo-Provera brain tumor link became widespread in 2024, many claimants’ discovery clocks started ticking recently. That means deadlines could fall in 2026 or 2027 for a large number of potential plaintiffs.
Do not assume you have unlimited time. If you were diagnosed with a meningioma and used Depo-Provera, the clock may already be running. Waiting too long could permanently bar your claim.
Some states have shorter windows. Others have exceptions for ongoing medical treatment. The safest move is to have your case evaluated sooner rather than later.
How to File a Depo Provera Lawsuit
Filing a Depo-Provera lawsuit starts with contacting a mass tort attorney who handles pharmaceutical injury cases. Most offer free case evaluations with no upfront cost.
Here is the typical filing process:
- Initial consultation. You share your medical history, Depo-Provera use, and diagnosis.
- Records review. The attorney obtains and reviews your medical records, pharmacy records, and imaging results.
- Case evaluation. The legal team determines whether your case meets the threshold for filing.
- Filing the complaint. Your attorney files a formal complaint in federal court or state court.
- Transfer to MDL. If filed federally, the case is transferred to MDL No. 3127 in Alabama.
- Pretrial process. Your case enters the discovery and bellwether preparation phase.
- Resolution. Your case is resolved through settlement or trial.
You do not need to travel to Alabama. The MDL system handles most proceedings without requiring plaintiffs to appear in person.
Most communication happens by phone, email, or secure online portals. Your attorney’s team manages the legal work while you focus on your health.
The entire process from initial contact to filing usually takes two to six weeks. Getting into the MDL system early can position you for faster resolution once settlements begin.
What Evidence Do You Need for a Depo Provera Lawsuit
The most critical evidence is medical documentation proving both your Depo-Provera use and your meningioma diagnosis. Without these two things, a case cannot move forward.
Strong cases include the following evidence:
- Pharmacy records confirming Depo-Provera prescriptions
- Medical records showing injection dates and dosages
- MRI or CT scans documenting the brain tumor
- Pathology reports confirming meningioma diagnosis
- Surgery records if tumor removal was performed
- Doctor statements noting potential link to hormonal contraception
- Employment records if you lost income due to the condition
- Insurance claims for treatments related to the tumor
If you cannot find your pharmacy records, your attorney can subpoena them from pharmacies, insurance companies, or healthcare providers. Records are often retrievable even from years ago.
Quick Tip: Request your complete medical records now, even before speaking with an attorney. Having everything organized speeds up the evaluation process.
The strongest cases combine long-term Depo-Provera use (three or more years), a confirmed meningioma diagnosis via imaging, and documented treatment or surgery. Gaps in the evidence don’t automatically disqualify you, but they can reduce the value of your claim.
Key Takeaway: Gather your pharmacy records, medical records, and imaging results now, because strong documentation is the single biggest factor separating high-value claims from weak ones.
Depo Provera Lawsuit Lawyer Fees
Most Depo-Provera lawsuit attorneys work on a contingency fee basis. That means you pay nothing upfront and nothing out of pocket during the case.
The attorney gets paid only if you receive a settlement or jury award. The standard contingency fee in mass tort cases ranges from 25% to 40% of the total recovery.
| Fee Structure | Details |
|---|---|
| Upfront cost | $0 |
| Contingency fee range | 25% to 40% |
| When you pay | Only if you win or settle |
| Case expenses | Usually deducted from settlement |
| Consultation fee | Free at most firms |
Case expenses (filing fees, medical record retrieval, expert witness costs) are typically advanced by the law firm and deducted from your settlement at the end.
Some firms charge lower percentages if the case settles before trial. Others charge a higher percentage if the case goes all the way through trial. Make sure you understand the fee agreement before signing.
This contingency model exists precisely so that people without money can still access the legal system. A woman recovering from brain surgery should not have to write a check to hire a lawyer. The system is designed to remove that barrier.
Read your retainer agreement carefully. Ask questions about the fee percentage, expense deductions, and what happens if the case is unsuccessful. A good attorney will explain everything in plain language.
Depo Provera Lawsuit Tax Implications
Settlement money from a Depo-Provera lawsuit is generally not taxable if it compensates for physical injuries or physical sickness. The IRS treats personal physical injury settlements differently from other types of income.
Here is how the tax treatment typically breaks down:
| Settlement Component | Taxable? |
|---|---|
| Compensation for physical injury | No |
| Medical expense reimbursement | No (if not previously deducted) |
| Pain and suffering (physical) | No |
| Lost wages | Yes |
| Punitive damages | Yes |
| Interest on settlement | Yes |
The key distinction is “physical” injury. Since meningioma is a physical condition requiring medical treatment, the core settlement amount should be tax-exempt under IRS Section 104(a)(2).
However, if part of your settlement includes compensation for lost wages, that portion is taxable as ordinary income. Punitive damages, if awarded separately, are always taxable.
Interest that accrues on settlement funds before distribution is taxable. If there is a delay between the verdict and payout, any interest earned during that period counts as income.
Consider consulting a tax professional when you receive your settlement. Structuring the payment correctly can make a significant difference in what you actually keep.
Some claimants opt for structured settlements, where the money is paid out over time rather than in a lump sum. This approach can reduce the tax impact in certain situations.
Key Takeaway: Most of your Depo-Provera settlement for physical injuries will be tax-free, but portions covering lost wages, punitive damages, or interest will be subject to federal income tax.
Frequently Asked Questions
How much money can I get from the Depo Provera lawsuit in 2026?
Individual payouts are projected to range from $25,000 to over $500,000 depending on injury severity.
Women who required brain surgery will likely receive the highest amounts.
No official settlement has been finalized yet, so these are estimates based on comparable pharmaceutical litigation.
What is the deadline to file a Depo Provera lawsuit?
The deadline depends on your state’s statute of limitations, typically two to three years from when you discovered the link between Depo-Provera and your diagnosis.
Many claimants’ clocks started in 2024 when media coverage became widespread.
Filing sooner protects your right to compensation.
Does the Depo Provera lawsuit cover all brain tumors or only meningioma?
The litigation primarily focuses on meningioma, the brain tumor type with the strongest scientific link to Depo-Provera.
Other intracranial tumors may qualify depending on the evidence.
Your attorney can evaluate whether your specific diagnosis fits within the litigation.
Do I need a lawyer to file a Depo Provera claim?
Yes, you need a lawyer, but you do not need money to hire one.
Most Depo-Provera attorneys work on contingency, meaning they charge nothing unless you win.
The legal process in an MDL is too complex for self-representation.
Will my Depo Provera settlement be taxed?
Compensation for physical injuries like meningioma is generally not taxable under IRS rules.
However, portions for lost wages, punitive damages, or interest are subject to federal income tax.
A tax professional can help you structure the payout to minimize your tax burden.
The Depo-Provera lawsuit is moving toward defining moments in 2026. Bellwether trials, filing deadlines, and growing scientific evidence all point to a year of real progress for claimants.
If you used Depo-Provera and have been diagnosed with a meningioma, take action now. Gather your medical records, check your state’s filing deadline, and get a free case evaluation from a qualified attorney.
Waiting costs you nothing today, but it could cost you everything if the statute of limitations runs out.
